Recruiting NCT06433817
Spectral CT in Radiotherapy for Cervical Cancer
For patients and families
In plain language
An automatic summary of structured registry data. It is an orientation aid, not a substitute for the official protocol or a physician assessment.
- What is being studied
- The protocol lists: Spectral computed tomography scan.
- Who it may be relevant to
- Registry conditions: Cervical Cancer, Radiotherapy. Basic parameters: from 18 years · Female.
- What needs checking
- Age, condition and sex are only basic indicators. Prior treatment, laboratory values and other mandatory requirements appear in the eligibility criteria below.
- Where it takes place
- China
- Next step
- Save the trial, show it to the treating physician, and confirm current recruitment with the study center. Costs, documents and travel →
Unsure about the terms? Read our patient guide →
Official title
The Clinical Research of Spectral CT in Radiotherapy for Cervical Cancer
Overview
The purpose of this study was to explore the potential application of spectral CT for radiotherapy in cervical cancer.
Interventions
- Radiation Spectral computed tomography scan
Spectral CT scans acquisition performed during the arterial phase and venous phase for cervical cancer
Primary outcome measures
- Comparison of spectral CT derived data with response evaluation in cervical cancer [Time frame: through study completion, an average of 2 year]
Secondary outcome measures (2)
- Identifying metastatic lymph nodes in cervical cancer with spectral CT [Time frame: through study completion, an average of 2 year]
- Application of energy spectrum CT in brachytherapy of cervical cancer [Time frame: through study completion, an average of 2 year]
Eligibility criteria
Inclusion criteria
- All patients were confirmed cervical cancer by pathology
- patients were treated with concurrent chemoradiotherapy
- Spectral CT scans acquisition performed during the arterial phase and venous phase
- All the patients underwent a 18F-FDG PET/CT before treatment
Exclusion criteria
- CT without spectral scans
- History of allergy to intravenous contrast
- Pregnant or potentially pregnant female subjects
Criteria are shown verbatim from the registry (in English). Final eligibility is always assessed by the study center.
Healthy volunteers: No
Study design
- Observational model
- Cohort
Study locations
China · 1 center
- Peking Union Medical College Hospital — Beijing
Identifiers
NCT: NCT06433817 · SPRTCC-Trial